
==== Front
CVIR Endovasc
CVIR Endovasc
CVIR Endovascular
2520-8934
Springer International Publishing Cham

39126551
473
10.1186/s42155-024-00473-3
Review Article
Interventional solutions for post-surgical problems: a lymphatic leaks review
http://orcid.org/0000-0003-0944-9819
Gómez Fernando M. fernan.m.gomez@gmail.com

123
Baetens Tarik R. 3
Santos Ernestos 4
Rocha Boris León 5
Horwitz Benjamín 6
Lojo-Lendoiro Sara 7
Vargas Patricio 6
Patel Premal 8
Beets-Tan Regina 3
Martínez-Rodrigo José J. 1
Bonmatí Luis Martí 1
1 grid.476458.c 0000 0004 0427 8560 Biomedical Imaging Research Group (GIBI2^30), La Fe Health Research Institute (IIS La Fe), Avenida Fernando Abril Martorell, València, 46026 Spain
2 grid.84393.35 0000 0001 0360 9602 Radiology Department, La Fe University and Polytechnic Hospital, Avenida Fernando Abril Martorell, València, 46026 Spain
3 https://ror.org/03xqtf034 grid.430814.a 0000 0001 0674 1393 Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX The Netherlands
4 grid.51462.34 0000 0001 2171 9952 Radiology, Division of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, USA
5 https://ror.org/02xtpdq88 grid.412248.9 Department of Interventional Radiology, Hospital Clínico de la Universidad de Chile, Santos Dumont 999, Independencia, Región Metropolitana Chile
6 grid.412187.9 0000 0000 9631 4901 Radiology Department, Facultad de Medicina Clínica Alemana-Universidad del Desarrollo, Santiago, 7650568 Chile
7 grid.411855.c 0000 0004 1757 0405 Department of Radiology, Hospital Álvaro Cunqueiro, Estrada de Clara Campoamor, 341, Vigo, Pontevedra 36312 Spain
8 https://ror.org/03zydm450 grid.424537.3 0000 0004 5902 9895 Great Ormond Street Hospital for Children NHS Foundation Trust, Renal Unit, Level 7, Southwood Building, Great Ormond Street, London, WC1N 3JH UK
10 8 2024
10 8 2024
12 2024
7 6117 4 2024
1 8 2024
© The Author(s) 2024, corrected publication 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The lymphatic circulation plays a crucial role in maintaining fluid balance and supporting immune responses by returning serum proteins and lipids to the systemic circulation. Lymphatic leaks, though rare, pose significant challenges post-radical neck surgery, oesophagectomy, and thoracic or retroperitoneal oncological resections, leading to heightened morbidity and mortality. Managing lymphatic leaks necessitates consideration of aetiology, severity, and volume of leakage.

Traditionally, treatment involved conservative measures such as dietary restrictions, drainage, and medical management, with surgical intervention reserved for severe cases, albeit with variable outcomes and extended recovery periods. Lymphography, introduced in the 1950s, initially served as a diagnostic tool for lymphoedema, lymphoma, tumour staging, and monitoring chemotherapy response. However, its widespread adoption was impeded by alternative techniques like Computed Tomography, learning curves, and its associated complications. Contemporary lymphatic interventions have evolved, favouring nodal lymphangiography over pedal lymphangiography for its technical simplicity and reduced complexity.

Effective management of chylous leaks mandates a multimodal approach encompassing clinical evaluation and imaging techniques. In cases where conservative management proves ineffective, embolization through conventional lymphangiography by bipedal dissection or intranodal injection emerges as a viable option. This review underscores the importance of a comprehensive approach to diagnosing and treating lymphatic leaks, highlighting advancements in imaging and therapeutic interventions that enhance patient outcomes.

Keywords

Lymhangiography
Surgical lymphatic leak
Embolization
issue-copyright-statement© Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and Springer International Publishing AG 2024
==== Body
pmcIntroduction

The lymphatic system (LS) is susceptible to be affected by various diseases, stemming from both malignant and benign origins. Among the primary causes of lymphatic leakages, we can find congenital anomalies and traumatic injuries affecting the LS [1]. Non-traumatic chyle leaks are frequently secondary to processes causing lymphatic obstruction, such as malignant occlusion, lymphatic vessel abnormality, systemic or congenital diseases, or idiopathic obstruction [2].

The most frequent causes of chyle leakage are iatrogenic injuries, mostly secondary to thoracic or abdominal surgery, with chylothorax rates as high as 3.9% after oesophagectomy [2] Typically, lymphatic leaks manifest in two scenarios: during surgical resections, particularly in oncological cases necessitating extensive lymphadenectomy, or in surgeries where the operative field intersects with major lymphatic vessels.

Traditionally, managing such complications leaned towards conservative measures [3]. However, persistent lymphatic leaks often prompted recourse to aggressive open or laparoscopic surgical interventions, albeit with associated morbidity, mortality, prolonged hospital stays and patient recovery periods [1, 3].

Initially, diagnostic procedures involved injecting blue dye between the toes, exposing a lymphatic vessel on the foot dorsum for cannulation after dissection, followed by ethiodized oil injection and serial radiography from the foot to the thorax to track contrast progression [3, 4].

Conventional lymphangiography (LA) emerged as a diagnostic tool in the 1950s, but with the advent of advanced imaging modalities such as ultrasound (US), computed tomography (CT), and magnetic resonance (MR), it was relegated to the background transitioning to a therapeutic modality with the introduction of thoracic duct (TD) embolization for chylothorax by Dr. Constantine Cope in the 90’s [3, 4]. During 2011 and 2012 intranodal lymphangiography surfaced as a simpler alternative [5–7]. Over recent decades, LA has ascended as a minimally invasive procedure, yielding favourable outcomes and witnessing technique refinements from pedal LA to encompass the treatment of diverse conditions like chylous ascites, paediatric chylothorax, plastic bronchitis, protein-losing enteropathy, lymphoceles, and thoracic duct stenting [8].

Anatomy

Besides the immune system’s transport network, the function of the LS is to return fluid and nutrients from interstitial tissues to the venous system. It is divided into three sections: soft tissue and extremities, hepatic and enteral lymphatics [9]. The hepatic and enteral lymphatics produce 80% of the lymphatic fluid, while the upper and lower extremities produce the remaining 20%. Lymph flows from the lower limbs, pelvis and abdomen to the Pecquet’s cistern or cisterna chyli (CC) and its continuation in the chest, the thoracic duct (TD) (Fig. 1a-d) [9, 10]. A smooth muscle layer composes the lymphatic duct walls and is susceptible to vagal, serotonin, norepinephrine, histamine and dopamine stimulation, increasing lymph flow, while opiates and octreotide decrease it [9].Fig. 1 a-d The chyle cistern (CC) (a-c) and thoracic duct (TD) (b, c). The CC is usually located at the level of L1-L2, and it has a linear (a) or oval (b) shape. Sometimes the TD can be seen in T2-weighted sequences on MRI, arrow (d)

The CC is commonly located between L1 and L2, parallel to and behind the inferior cava vein, joining the TD in the upper third of the abdomen, deep to the arcuate ligament. It is present in 65% to 85% of patients and its shape is variable: oval (50%), linear (40%) or round (10%) [7] (Fig 1a, b). It can measure up to 5 cm in length and average diameter of 6-7 mm [9]. The intestinal, hepatic and lumbar trunks drain the lymph/chyle into the CC. Cephalad and in the chest, the TD is located parallel and to the right of the oesophagus, crossing to the left at the approximate level of the middle third of the thoracic vertebral bodies, where it lies anterior to the intercostal branches of the thoracic aorta. Then, it rises to the dome pleura and drains into the left subclavian vein, next to the jugular subclavian confluence (Fig. 1d). TD mesures approximately 45 cm in length and 2-5 mm in diameter. The anatomy of the TD and CC is variable (normal anatomy in 40-60% of the patients) with a variable crossing level, number of thoracic collaterals (which increase surgical complexity) and the anatomy of venous-lymphatic anastomosis with the left subclavian vein (single trunk with a big caliber or several small vessels) (Fig. 2a, b). These anatomic variants should be carefully considered when planning a retrograde embolization [11].Fig. 2 a, b Venolymphatic Anastomosis. a Retrograde catheterization with an angiographic catheter (arrow head) of the TD showing a single anastomosis (single arrow). b 3D Computed Tomography reconstruction in a TD junction showing multiple anastomosis (multiple arrows)

Technical approach

LA is a minimally invasive radiological technique in which the contrast is injected into the LS after puncturing a duct or a lymph node with a thin needle (usually thinner than 24G). The preferred contrast medium is lipiodol, but other agents such as water-soluble iodinated contrast or gadolinium can also be applied mainly for diagnostic purposes on CT or MR scans [12]. Ethiodized oil (lipiodol®, Gerbet…) is a lipid based iodinated contrast, consisting of iodine molecules combined with fatty acids from poppy seed oil, which generates a continuous column of contrast due to its chemical properties. Interestingly, it can cause in some cases sclerosis and occlusion of the leak achieving a therapeutic effect, this happens between 50% and 75% of the cases being more frequent when the volume of the leak is below 500cc/24h [13–15].

The recommended maximum total dose should not exceed 20mL. An appraisal of a suitable volume has been proposed at a maximum dose of 0.25 ml/kg [16]. However, according to the authors experience, when a leak is clearly present, use of higher doses can be reasonable as most of the lipiodol will not be delivered to the venous system. Once injected into the LS, contrast follows the lymph course from extremities towards pelvis, abdomen and finally thorax.

Conventional bipedal LA is regarded as a complex procedure due to the intricate steps involved. The interventionist is required to identify and isolate a lymphatic vessel on the foot after administering a dye (0.5 cc of methylene blue or blue Isosulfan 1%) into the web spaces of the toes. Once the operator identifies the staining of the lymphatic vessels, a dissection is made on the dorsum of the foot to find the access into the vessel with a fine needle (27 gauge - 30 gauge) [4, 17]. X-ray images of the extremity are planned every 15 min, while for the abdomen it may require up to 2-5 hrs. Recently, intranodal LA has emerged as a simpler and less invasive alternative to traditional bipedal LA. It consists of a lymph node ultrasound-guided percutaneous puncture, usually in the inguinal region (potentially can be performed on any lymph node), with then a direct injection of the contrast medium (Fig. 3). This technique is easier than the classic approach, makes diagnostic LA compatible with the basic skills of any interventional radiologist and decreases the time duration of the study [5]. With this method, it may take than 1h for the contrast to reach the abdomen [4]. It has been reported a technical success rate of up to 87% for IL [16–19]. Although the evidence supporting this access is recent, its first description was made in 1930 by Funaoka [20]. The technical objective is to precisely position the tip of a fine needle (ranging from 23G to 26G), ideally at the corticomedullary junction. Then the needle is connected to a variable volume syringe or a pump and the contrast is injected at a rate of 5-10 mL/h under intermittent fluoroscopic vision after confirming the correct progression of the contrast column. If the location of the needle is correct, the operator could see opacification of the lymph node and its efferent lymphatic ducts. If contrast flows out of the lymph node, the needle must be repositioned unless minimal extravasation happens and clear progression of lipiodol is confirmed. When performing this technique on the groin, the same process can be repeated in the contralateral side to shorten the duration of the procedure [4–6].Fig. 3 a, b Transnodal lymphangiography showing filling of inguinal lymphatic vessels and lymphatic nodes (a). Approximately 30 minutes after the beginning of the injection iliac lymphatic vessels and nodes are depicted (b)

The calculated total dose of contrast must be divided into the number of lymph nodes to be punctured. Lipiodol injection can be continued until the maximum dose to get a greater embolic effect. If the total dose is injected before reaching the third lumbar body level or the desired level (i.e., the thoracic duct), then the operator may facilitate the spread of the contrast administering 1 mL/5 min saline [9]. Warming the lipiodol can help to achieve higher speed of contrast injection since old lymphangiography pumps heated lipiodol while injecting. To evaluate lipiodol circulation, the operator can observe the lymphatic distribution with fluoroscopic vision, immediately after its injection and at 1, 3, 5, 10, 15, 30, and 45 min (Fig. 3b). According to the speed of distribution of contrast and in order to find the lymphatic leak, in cases when it is not visualised during the procedure, the operator can complete the study with abdominal and chest radiographs in 12-24hrs, or CT or MRI. Both of these methods have also been employed to assess a patient's response to therapy [9, 17]. Once the leak has been demonstrated, physicians should decide its management. The first to describe a successful percutaneous treatment for chylothorax was Cope in 1998 [3]; later, lipiodol lymphangiography and transnodal glue embolization were used to treat pelvic leaks [21, 22]. Once the TD and/or CC are depicted, then it is possible to perform selective catheterization and embolization, as described in the following methods:

Antegrade percutaneous transabdominal access

A fine needle (21G-22G, measuring 15cm-20cm in length) guided by fluoroscopy is utilised for the procedure. The objective is to puncture the CC. If the CC is not identified, an alternative is to puncture the abdominal portion of the TD. Subsequently, a microwire (0.014" or 0.018") is inserted into the CC or TD, followed by the advancement of a microcatheter. If the leak can be identified at this stage, the operator should aim for maximal selectivity before proceeding to inject the embolic agent (Fig. 4a). In certain scenarios, a through-through technique may be employed to enhance stability and effectively embolize leaks, particularly those located at lower levels, such as abdominal leaks.Fig. 4 a-c CC percutaneous transabdominal anterograde fluoroscopy guided access using a 22 G needle (a). Insertion of a 0,018 ´ ´ guidewire in the TD through the CC (b). Progression of a 2.4 microcatheter and subsequent coiling as scaffold for glue embolization (c)

Retrograde catheterization from the subclavian vein

TD can be accessed at the level of its anastomosis with the subclavian vein, either after intravenous access or by direct puncture guided by ultrasound or fluoroscopy when it is opacified [23]. This method may be difficult if the size of the lymphatic vessel or vessels forming the anastomosis are small or in cases where a complete postoperative section of the TD occurred [8] (Fig. 2). Balloon-occluded endolymphatic retrograde abdominal lymphangiography (BORAL) and embolisation (BORALE) are novel techniques used for the diagnosis and treatment of chylous ascites. These techniques use an occlusion balloon placed into the TD to prevent reflux of sclerosing material when diagnosing and treating abdominal lymphatic leaks [24]. Another option is to perform US guided direct puncture of the thoracic duct close to the subclavian level. The thoracic duct can be accessed after lipiodol lymphangiography or by means of ultrasound or fluoroscopic guidance [25–27]. Once access is established, the embolization begins.

Indications

LA, either alone or in combination with embolization, serves as a viable diagnostic and/or treatment option for conditions such as chylothorax, chylous ascites, lymphoceles, and chylopericardium.

Chylothorax

Chylothorax is the presence of lymphatic or chylous fluid in pleural space. Milky pleural fluid with a triglyceride concentration greater than 110 mg/dl or the presence of chylomicrons on lipoprotein electrophoresis confirms the diagnosis of chylothorax [28]. The most common cause is due to iatrogenic trauma during surgery, chylothorax has been reported in 0.42% of cases of thoracic surgery [29]. Non-traumatic causes have also been described, with malignant disorders being the most frequent, especially in patients affected by lymphoma or pulmonary cancer. As a consequence of invasion or compression by the tumour, the pressure in the lymph vessels increases, making them more susceptible to lymphatic extravasation. Other causes are idiopathic, congenital, autoimmune or infectious (mainly tuberculosis) [11, 14, 15].

Management of chylothorax depends on its severity. Chylothorax is considered to be low output when there is a loss of less than 500 cc per day, and it can be treated conservatively, with a low-fat diet, parenteral nutrition, octreotide administration and pleural drainage tubes. These conservative measures are successful in up to 50-60% of the cases [30].

High output chylothorax is defined when there is loss of more than 1000 cc of lymph in 24h; and often is not controlled with conservative measures. In these cases, patients suffer loss of nutrients, immune cells and proteins, resulting in a high morbidity and mortality [15]. Traditionally it has been approached surgically by attempting TD ligation by means of video assisted thoracoscopic surgery (VATS). Conversion to open thoracotomy is performed when it is not possible to locate the TD thoracoscopically but it is associated with higher morbidity and mortality rates (2.1% vs. 38.8%respectively) [31]. Reported surgical success rates are 70% in children [7] and range between 70% and 100% in adults [32]. Other surgical alternatives are the creation of a pleuroperitoneal shunt and pleurodesis.

LA, with or without TD embolization, offers a less invasive approach supported by growing evidence demonstrating favourable outcomes in both adult and paediatric populations, including patients that recurred post-surgery [11, 15]. Decision-making typically hinges on individual patient evolution following conservative interventions when chyle output falls within the range between two breakpoints (> 500cc and <1000cc/day) [2] (Fig. 4b, c).

Chylous ascites

Similar to chylothorax, the aetiology of chylous ascites can be traumatic or non-traumatic. Non-traumatic causes include inflammatory and infectious diseases like tuberculosis, filariasis, radiation, pancreatitis neoplasms as lymphoma traumatic or postoperative causes encompass blunt abdominal trauma, aortic surgery and retroperitoneal lymphadenectomy, among others [33, 34]. Typically, management commences with a conservative approach. In recurrent or severe cases, surgical alternatives may be considered.

Despite interventional procedures have been documented in the management of chylous ascites, the effectiveness is lower than thoracic duct embolization for chylothorax. Approximately 55% of patients with chylous ascites have lipiodol extravasation detected with LA which makes more difficult to define the best treatment strategy. The success of LA and embolization is closely tied to the accurate representation of the leak [34]. Several percutaneous procedures have been described in this clinical setting including TD embolization, BORALE technique, mesenteric lymphangiography and interstitial embolization [10, 24, 34]. When lymphatic leak is not demonstrated following groin lymph node injection direct puncture of a mesenteric lymph node can be beneficial (Fig 5a, b). Direct access to the leak, along with catheterization and embolization, or retrograde access with balloon occlusion and embolization, may also yield effective occlusion of the leak [24, 35] (Fig. 6a-c). Furthermore, in certain clinical scenarios, such as chylous ascites post-pancreatic or liver surgery, transhepatic lymphatic embolization has demonstrated efficacy in treating the leak [36–38] (Fig 7a-c).Fig. 5 a, b Ultrasound guided puncture of a mesenteric lymph node (a) and mesenteric lymphangiography (b)

Fig. 6 a-c Tansabdominal access through the CC and wire snearing (arrow) via subclavian vein approach (a). Balloon inflated at T12 L1 level (arrow) Retrograde injection of contrast with demonstration of the leak at the pancreatic bed (b). Percutaneous embolization (arrow) with glue (c)

Fig. 7 a-c Transhepatic Computed Tomography lymphangiography (a) showing a lymphatic leak (arrow) (b) and subsequent embolization using Glue (1:3) (c)

Pelvic leaks

Lymphocele is defined as the presence of a collection of lymph surrounded by a capsule without epithelium. In the pelvis and groin, lymphatic leakage occurs most frequently after renal transplantation, surgeries affecting the vascular bundle and lymphadenectomy performed after prostatectomy or other surgeries in the pelvis [21].

The main surgical technique described is an open drainage and marsupialisation. On the other hand, interventional techniques include percutaneous drainage and sclerotherapy. This involves drainage catheter insertion into the collection under image guidance (US, CT or fluoroscopy) and injection of a sclerosant agent for a variable period of time during collection, which is then removed [39]. There are different agents described in literature: among others are doxycycline, bleomycin, sodium tetradecyl sulphate, ethanol or absolute alcohol, povidone iodine and tetracycline [39–41]. Although this treatment is sometimes successful after one session, based on the current evidence, the average number of sclerotherapy procedures to remove the drain ranges from 1 to 4.

In cases of severe leakage or recurrence, it is possible to identify the direct leak from a lymphatic duct. In this context, LA has been recommended for diagnosis of possible leaks and their treatment [21, 22] (Fig. 8a, b). Several authors have proposed a mixed treatment, prioritising a minimal invasive approach as the first measure. Hamza et al [42] described a treatment algorithm for post-renal transplant lymphocele, with percutaneous treatment performed as the first option and, in cases of recurrence or difficult access, surgical treatment (Fig 9). For these patients, or those with lymphatic leakage after surgery, interstitial lymphatic embolisation by direct nodal puncture and glue injection (N-CBA mixed with lipiodol 1:3 or 1:4) has also been described as an effective treatment and it may offer a shorter time to drain removal compared to sclerotherapy [43] (Fig 10).Fig. 8 a, b Transnodal lymphangiography in a retroperitoneal lymphocele showing Lipiodol leak (arrow) (a). Computed tomography depicting Lipiodol droplets inside the lymphocele (multiple arrows) (b)

Fig. 9 Lymphangiography showing a lymphatic leak in a post-trasplant lymphocele (arrow)

Fig. 10 Massive left lymphatic leak after bilateral retroperitoneal iliac lymphadenectomy embolized by beans of glue 1:3

Complications

The complication rate following LA and lymphatic embolization ranges from 0% to 3% [8, 14, 16]. The main risk of using lipiodol in LA is non-target embolization to lungs or brain. The underlying mechanism for how lipiodol reaches the cerebral circulation may involve right-to-left intracardiac shunt so previously performing an echocardiogram is recommended [35]. Other reported complications include the alteration of thyroid function in patients with hyper or hypothyroidism and impaired renal function [16].

Embolization of non-target territories, particularly the pulmonary arteries, stands out as one of the most frequently reported complications [14]. Lipiodol embolization in the cerebral arterial territory leading to secondary cerebral stroke has also been described [15, 39]. Other potential complications may include bleeding or infection associated with percutaneous access. Embolization to the portal territory has also been documented following transhepatic approach. Furthermore, Lipiodol use has been associated with alterations in thyroid function in patients with hyper or hypothyroidism and impaired renal function [16]. Delayed complications following thoracic duct embolization can have an overall incidence rate as high as 14.3% and may include chronic diarrhoea, chronic leg swelling, and abdominal swelling [34].

Discussion

Lymphatic leaks and effusions can arise from congenital conditions or traumatic injuries to the LS. Typically, surgical management of these leaks entails complex and aggressive interventions, often struggling to pinpoint the source of the problem. Traditional bipedal LA presents itself as a cumbersome technique widely utilised for lymphatic system evaluation and tumour staging prior to the emergence of cross-sectional imaging. However, the advent of CT and MRI led to a decline in the use of LA and a gradual disappearance of pedal dissection from the repertoire of radiologists, contributing to its diminished utilisation.

The development of intranodal LA and various percutaneous approaches has streamlined the technique, rendering it more accessible to interventional radiologists of varying skill levels. Nevertheless, with the availability of less invasive diagnostic imaging techniques like dynamic MRI lymphangiography, which not only evaluates the origin of a lymphatic leak but also facilitates therapeutic planning [44], lipiodol LA should be reserved for cases necessitating immediate treatment within the same procedure.

However, published evidence is primarily derived from retrospective studies, each employing different treatment protocols and a variety of embolic agents. Consequently, comparing the efficacy of these agents proves challenging. Reported success rates vary widely, ranging from 74% to 100% [24–27]. The assortment of embolic agents utilised includes coils, ethylene vinyl alcohol (EVOH), cyanoacrylates, alcohol, either alone or in combination [8, 17, 20]. For glue embolization, described dilutions typically range between 1:2 or 1:2.5 [13, 15]. Notably, Itkin et al. advocate for using coils as a scaffold to support subsequently injected glue, thus minimising the risk of unintended embolization [17]. They also recommend using glue alone in cases where coil embolization is hindered by limited space. In situations where cannulation of the TD or CC is not feasible, CC disruption can be performed under fluoroscopic guidance or computed tomography vision [8, 15, 27].

Management should adopt a multidisciplinary approach, commencing with conservative treatment and escalating to more invasive alternatives only in cases of treatment failure. Given the relatively low number of patients with lymphatic complications and the technical complexity of cases requiring embolization, centres with ample experience should undertake LA and percutaneous embolization for lymphatic leaks in the pelvis, abdomen, or thorax.

Although there are no trials comparing the effectiveness of surgical repair versus lymphatic embolization, the efficacy of LA and embolization, coupled with their low rate of major complications, makes it ethically questionable to conduct such trials. As a result, surgery should be reserved solely for cases where percutaneous embolization proves unsuccessful.

Conclusions

LA and embolization should be considered the treatment of choice for complex postsurgical lymphatic leaks after failure of conservative treatment. It is important that these treatments are managed multidisciplinarity and performed in experienced centres, evaluating minimally invasive treatment options to accelerate the patient's recovery and potentially improve results.

Abbreviations

LS Lymphatic system

LA Lymphangiography

CT Computed tomography

MR Magnetic Resonance Imaging

CC Chili cistern

TD Thoracic duct

EVOH Ethylene vinyl alcohol

Acknowledgements

NA.

Authors’ contributions

Each author has sufficiently contributed to this manuscript. Study conception and design: FGM, TRB, BL, ES; Data Collection: ES, BH, PV, BL, TRB, FGM; Draft manuscript preparation: FGM, TRB, BL, ES, SLL, PP; Manuscript review: PP, RBT, JJMR, LMB, SLL. All authors reviewed the results and approved the final version of the manuscript.

Funding

The work received no funding.

Availability of data and materials

NA.

Declarations

Ethics approval and consent to participate

NA. Narrative review not requiring IRB approval.

Consent for publication

NA.

Competing interests

None of the authors has any competing interest.

The original online version of this article was revised: Following publication of the original article [1], the author reported that the affiliations 3 and 4 have been interchanged.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Majdalany BS El-Haddad G Contemporary lymphatic interventions for postoperative lymphatic leaks Transl Androl Urol. 2020 9 Suppl 1 S104 S113 10.21037/tau.2019.08.15 32055491
Majdalany BS, El-Haddad G. Contemporary lymphatic interventions for postoperative lymphatic leaks. Transl Androl Urol. 2020;9(Suppl 1):S104–13.32055491
2. Zurcher KS Huynh KN Khurana A Majdalany BS Toskich B Kriegshauser JS Patel IJ Naidu SG Oklu R Alzubaidi SJ Interventional Management of Acquired Lymphatic Disorders Radiographics. 2022 42 6 1621 1637 10.1148/rg.220032 36190865
Zurcher KS, Huynh KN, Khurana A, Majdalany BS, Toskich B, Kriegshauser JS, Patel IJ, Naidu SG, Oklu R, Alzubaidi SJ. Interventional management of acquired lymphatic disorders. Radiographics. 2022;42(6):1621–37.36190865
3. Cope C Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study J Vasc Interv Radiol 1998 9 5 727 34 10.1016/S1051-0443(98)70382-3 9756057
Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. J Vasc Interv Radiol. 1998;9(5):727–34.9756057
4. Itkin M Kucharczuk JC Kwak A Trerotola SO Kaiser LR Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients J Thorac Cardiovasc Surg. 2010 139 3 584 89 10.1016/j.jtcvs.2009.11.025 20042200
Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg. 2010;139(3):584–9.20042200
5. Nadolski GJ Itkin M Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization J Vasc Interv Radiol. 2012 23 5 613 6 10.1016/j.jvir.2012.01.078 22440590
Nadolski GJ, Itkin M. Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization. J Vasc Interv Radiol. 2012;23(5):613–6.22440590
6. Rajebi MR Chaudry G Padua HM Dillon B Yilmaz S Arnold RW Landrigan-Ossar MF Alomari AI Intranodal lymphangiography: feasibility and preliminary experience in children J Vasc Interv Radiol. 2011 22 9 1300 5 10.1016/j.jvir.2011.05.003 21715187
Rajebi MR, Chaudry G, Padua HM, Dillon B, Yilmaz S, Arnold RW, Landrigan-Ossar MF, Alomari AI. Intranodal lymphangiography: feasibility and preliminary experience in children. J Vasc Interv Radiol. 2011;22(9):1300–5.21715187
7. Gómez FM Martínez-Rodrigo J Martí-Bonmatí L Santos E Forner I Lloret M Pérez-Enguix D García-Marcos R Transnodal lymphangiography in the diagnosis and treatment of genital lymphedema Cardiovasc Intervent Radiol. 2012 35 6 1488 91 10.1007/s00270-012-0445-6 22864605
Gómez FM, Martínez-Rodrigo J, Martí-Bonmatí L, Santos E, Forner I, Lloret M, Pérez-Enguix D, García-Marcos R. Transnodal lymphangiography in the diagnosis and treatment of genital lymphedema. Cardiovasc Intervent Radiol. 2012;35(6):1488–91.22864605
8. Majdalany BS Sanogo ML Pabon-Ramos WM Wilson KA Goswami AK Kokabi N Khaja MS Complications during Lymphangiography and Lymphatic Interventions Semin Intervent Radiol. 2020 37 3 309 317 10.1055/s-0040-1713448 32773956
Majdalany BS, Sanogo ML, Pabon-Ramos WM, Wilson KA, Goswami AK, Kokabi N, Khaja MS. Complications during Lymphangiography and Lymphatic Interventions. Semin Intervent Radiol. 2020;37(3):309–17.32773956
9. Goswami AK Khaja MS Downing T Kokabi N Saad WE Majdalany BS Lymphatic Anatomy and Physiology Semin Intervent Radiol 2020 37 3 227 236 10.1055/s-0040-1713440 32773948
Goswami AK, Khaja MS, Downing T, Kokabi N, Saad WE, Majdalany BS. Lymphatic anatomy and physiology. Semin Intervent Radiol. 2020;37(3):227–36.32773948
10. Aalami OO Allen DB Organ CH Jr Chylous ascites: a collective review Surgery. 2000 128 5 761 78 10.1067/msy.2000.109502 11056439
Aalami OO, Allen DB, Organ CH Jr. Chylous ascites: a collective review. Surgery. 2000;128(5):761–78.11056439
11. Lyon S Mott N Koukounaras J Shoobridge J Hudson PV Role of interventional radiology in the management of chylothorax: a review of the current management of high output chylothorax Cardiovasc Intervent Radiol. 2013 36 3 599 607 10.1007/s00270-013-0605-3 23580112
Lyon S, Mott N, Koukounaras J, Shoobridge J, Hudson PV. Role of interventional radiology in the management of chylothorax: a review of the current management of high output chylothorax. Cardiovasc Intervent Radiol. 2013;36(3):599–607.23580112
12. Shaikh R Biko DM Lee EY MR Imaging Evaluation of Pediatric Lymphatics: Overview of Techniques and Imaging Findings Magn Reson Imaging Clin N Am. 2019 27 2 373 385 10.1016/j.mric.2019.01.011 30910103
Shaikh R, Biko DM, Lee EY. MR imaging evaluation of pediatric lymphatics: overview of techniques and imaging findings. Magn Reson Imaging Clin N Am. 2019;27(2):373–85.30910103
13. Syed LH Georgiades CS Hart VL Lymphangiography: a case study Semin Intervent Radiol. 2007 24 1 106 10 10.1055/s-2007-971180 21326747
Syed LH, Georgiades CS, Hart VL. Lymphangiography: a case study. Semin Intervent Radiol. 2007;24(1):106–10.21326747
14. Guermazi A Brice P Hennequin C Sarfati E Lymphography: an old technique retains its usefulness Radiographics 2003 23 6 1541 58 10.1148/rg.236035704 14615563
Guermazi A, Brice P, Hennequin C, Sarfati E. Lymphography: an old technique retains its usefulness. Radiographics. 2003;23(6):1541–58 discussion 1559-60.14615563
15. Choo JC Foley PT Lyon SM Percutaneous management of high-output chylothorax: case reviews Cardiovasc Intervent Radiol. 2009 32 4 828 32 10.1007/s00270-009-9545-3 19296159
Choo JC, Foley PT, Lyon SM. Percutaneous management of high-output chylothorax: case reviews. Cardiovasc Intervent Radiol. 2009;32(4):828–32.19296159
16. Itkin M Krishnamurthy G Naim MY Bird GL Keller MS Percutaneous thoracic duct embolization as a treatment for intrathoracic chyle leaks in infants Pediatrics. 2011 128 1 e237 41 10.1542/peds.2010-2016 21646254
Itkin M, Krishnamurthy G, Naim MY, Bird GL, Keller MS. Percutaneous thoracic duct embolization as a treatment for intrathoracic chyle leaks in infants. Pediatrics. 2011;128(1):e237-41.21646254
17. Xiong L Engel H Gazyakan E Rahimi M Hünerbein M Sun J Kneser U Hirche C Current techniques for lymphatic imaging: State of the art and future perspectives Eur J Surg Oncol. 2014 40 3 270 6 10.1016/j.ejso.2013.11.027 24368048
Xiong L, Engel H, Gazyakan E, Rahimi M, Hünerbein M, Sun J, Kneser U, Hirche C. Current techniques for lymphatic imaging: State of the art and future perspectives. Eur J Surg Oncol. 2014;40(3):270–6.24368048
18. Zheutlin N Shanbrom E Contrast visualization of lymph nodes Radiology. 1958 71 5 702 8 10.1148/71.5.702 13602103
Zheutlin N, Shanbrom E. Contrast visualization of lymph nodes. Radiology. 1958;71(5):702–8.13602103
19. Klotz R Kuner C Pan F Feißt M Hinz U Ramouz A Klauss M Chang DH Do TD Probst P Sommer CM Kauczor HU Hackert T Büchler MW Loos M Therapeutic lymphography for persistent chyle leak after pancreatic surgery HPB (Oxford). 2022 24 5 616 623 10.1016/j.hpb.2021.09.019 34702626
Klotz R, Kuner C, Pan F, Feißt M, Hinz U, Ramouz A, Klauss M, Chang DH, Do TD, Probst P, Sommer CM, Kauczor HU, Hackert T, Büchler MW, Loos M. Therapeutic lymphography for persistent chyle leak after pancreatic surgery. HPB (Oxford). 2022;24(5):616–23.34702626
20. Davidson JW Fletch AL McIlmoyle G Roeck W The technique and applications of lymphography Can J Comp Med. 1973 37 2 130 8 4348732
Davidson JW, Fletch AL, McIlmoyle G, Roeck W. The technique and applications of lymphography. Can J Comp Med. 1973;37(2):130–8.4348732
21. Smolock AR Nadolski G Itkin M Intranodal Glue Embolization for the Management of Postsurgical Groin Lymphocele and Lymphorrhea J Vasc Interv Radiol 2018 29 10 1462 1465 10.1016/j.jvir.2018.04.020 30217746
Smolock AR, Nadolski G, Itkin M. Intranodal glue embolization for the management of postsurgical groin lymphocele and lymphorrhea. J Vasc Interv Radiol. 2018;29(10):1462–5.30217746
22. Seyferth ER Itkin M Nadolski GJ Intranodal Glue Embolization for Postoperative Lymphatic Leaks in the Groin and Pelvis: Comparison with Sclerotherapy J Vasc Interv Radiol. 2023 34 4 600 606 10.1016/j.jvir.2022.12.031 36563935
Seyferth ER, Itkin M, Nadolski GJ. Intranodal glue embolization for postoperative lymphatic leaks in the Groin and Pelvis: Comparison with Sclerotherapy. J Vasc Interv Radiol. 2023;34(4):600–6.36563935
23. Chung A Gill AE Rahman FN Hawkins CM Retrograde Thoracic Duct Embolization in a Pediatric Patient with Total Cavopulmonary Connection and Plastic Bronchitis J Vasc Interv Radiol. 2015 26 11 1743 6 10.1016/j.jvir.2015.07.023 26505943
Chung A, Gill AE, Rahman FN, Hawkins CM. Retrograde thoracic duct embolization in a pediatric patient with total cavopulmonary connection and plastic bronchitis. J Vasc Interv Radiol. 2015;26(11):1743–6.26505943
24. Srinivasa RN Gemmete JJ Osher ML Hage AN Chick JFB Endolymphatic Balloon-Occluded Retrograde Abdominal Lymphangiography (BORAL) and Embolization (BORALE) for the Diagnosis and Treatment of Chylous Ascites: Approach, Technical Success, and Clinical Outcomes Ann Vasc Surg. 2018 49 49 56 10.1016/j.avsg.2017.10.020 29217440
Srinivasa RN, Gemmete JJ, Osher ML, Hage AN, Chick JFB. Endolymphatic Balloon-Occluded Retrograde Abdominal Lymphangiography (BORAL) and Embolization (BORALE) for the Diagnosis and Treatment of Chylous Ascites: Approach, Technical Success, and Clinical Outcomes. Ann Vasc Surg. 2018;49:49–56.29217440
25. Guevara CJ Rialon KL Ramaswamy RS Kim SK Darcy MD US-Guided, Direct Puncture Retrograde Thoracic Duct Access, Lymphangiography, and Embolization: Feasibility and Efficacy J Vasc Interv Radiol. 2016 27 12 1890 1896 10.1016/j.jvir.2016.06.030 27595470
Guevara CJ, Rialon KL, Ramaswamy RS, Kim SK, Darcy MD. US-Guided, Direct puncture retrograde thoracic duct access, lymphangiography, and embolization: feasibility and efficacy. J Vasc Interv Radiol. 2016;27(12):1890–6.27595470
26. Cope C Salem R Kaiser LR Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial J Vasc Interv Radiol. 1999 10 9 1248 54 10.1016/S1051-0443(99)70227-7 10527204
Cope C, Salem R, Kaiser LR. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol. 1999;10(9):1248–54.10527204
27. Bundy JJ Chick JF Jiao A Cline MR Srinivasa RN Khayat M Gnannt R Johnson EJ Gemmete JJ Monroe EJ Srinivasa RN Percutaneous fluoroscopically-guided transcervical retrograde access facilitates successful thoracic duct embolization after failed antegrade transabdominal access Lymphology. 2019 52 2 52 60 10.2458/lymph.4626 31525826
Bundy JJ, Chick JF, Jiao A, Cline MR, Srinivasa RN, Khayat M, Gnannt R, Johnson EJ, Gemmete JJ, Monroe EJ, Srinivasa RN. Percutaneous fluoroscopically-guided transcervical retrograde access facilitates successful thoracic duct embolization after failed antegrade transabdominal access. Lymphology. 2019;52(2):52–60.31525826
28. Maldonado F Hawkins FJ Daniels CE Doerr CH Decker PA Ryu JH Pleural fluid characteristics of chylothorax Mayo Clin Proc. 2009 84 2 129 33 10.4065/84.2.129 19181646
Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc. 2009;84(2):129–33.19181646
29. Boffa DJ Sands MJ Rice TW Murthy SC Mason DP Geisinger MA Blackstone EH A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery Eur J Cardiothorac Surg. 2008 33 3 435 9 10.1016/j.ejcts.2007.11.028 18207415
Boffa DJ, Sands MJ, Rice TW, Murthy SC, Mason DP, Geisinger MA, Blackstone EH. A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg. 2008;33(3):435–9.18207415
30. Alejandre-Lafont E Krompiec C Rau WS Krombach GA Effectiveness of therapeutic lymphography on lymphatic leakage Acta Radiol. 2011 52 3 305 11 10.1258/ar.2010.090356 21498367
Alejandre-Lafont E, Krompiec C, Rau WS, Krombach GA. Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiol. 2011;52(3):305–11.21498367
31. Jacob S Meneses A Landolfo K El-Sayed Ahmed M Makey IA Pham SM Thomas M Incidence, Management, and Outcomes of Chylothorax after Lung Transplantation: A Single-center Experience Cureus 2019 11 7 e5190 31341753
Jacob S, Meneses A, Landolfo K, El-Sayed Ahmed M, Makey IA, Pham SM, Thomas M. Incidence, Management, and Outcomes of Chylothorax after Lung Transplantation: A Single-center Experience. Cureus. 2019;11(7):e5190.31341753
32. Le Coultre C Oberhänsli I Mossaz A Bugmann P Faidutti B Belli DC Postoperative chylothorax in children: differences between vascular and traumatic origin J Pediatr Surg. 1991 26 5 519 23 10.1016/0022-3468(91)90696-Q 2061800
Le Coultre C, Oberhänsli I, Mossaz A, Bugmann P, Faidutti B, Belli DC. Postoperative chylothorax in children: differences between vascular and traumatic origin. J Pediatr Surg. 1991;26(5):519–23.2061800
33. Lambertz R Chang DH Hickethier T Bagheri M Leers JM Bruns CJ Schröder W Ultrasound-guided lymphangiography and interventional embolization of chylous leaks following esophagectomy Innov Surg Sci. 2019 4 3 85 90 31709299
Lambertz R, Chang DH, Hickethier T, Bagheri M, Leers JM, Bruns CJ, Schröder W. Ultrasound-guided lymphangiography and interventional embolization of chylous leaks following esophagectomy. Innov Surg Sci. 2019;4(3):85–90.31709299
34. Laslett D Trerotola SO Itkin M Delayed complications following technically successful thoracic duct embolization J Vasc Interv Radiol. 2012 23 1 76 9 10.1016/j.jvir.2011.10.008 22115569
Laslett D, Trerotola SO, Itkin M. Delayed complications following technically successful thoracic duct embolization. J Vasc Interv Radiol. 2012;23(1):76–9.22115569
35. Kirschen MP Dori Y Itkin M Licht DJ Ichord R Vossough A Cerebral Lipiodol Embolism after Lymphatic Embolization for Plastic Bronchitis J Pediatr. 2016 176 200 3 10.1016/j.jpeds.2016.05.036 27297208
Kirschen MP, Dori Y, Itkin M, Licht DJ, Ichord R, Vossough A. Cerebral Lipiodol Embolism after Lymphatic Embolization for Plastic Bronchitis. J Pediatr. 2016;176:200–3.27297208
36. Ching KC Santos E McCluskey K Jeyabalan G CT-guided injection of N-butyl cyanoacrylate glue for treatment of chylous leak after aorto-mesenteric bypass Cardiovasc Intervent Radiol. 2014 37 4 1103 6 10.1007/s00270-013-0811-z 24318463
Ching KC, Santos E, McCluskey K, Jeyabalan G. CT-guided injection of N-butyl cyanoacrylate glue for treatment of chylous leak after aorto-mesenteric bypass. Cardiovasc Intervent Radiol. 2014;37(4):1103–6.24318463
37. Nadolski GJ Chauhan NR Itkin M Lymphangiography and Lymphatic Embolization for the Treatment of Refractory Chylous Ascites Cardiovasc Intervent Radiol. 2018 41 3 415 423 10.1007/s00270-017-1856-1 29238869
Nadolski GJ, Chauhan NR, Itkin M. Lymphangiography and lymphatic embolization for the treatment of refractory chylous ascites. Cardiovasc Intervent Radiol. 2018;41(3):415–23.29238869
38. Guez D Nadolski GJ Pukenas BA Itkin M Transhepatic lymphatic embolization of intractable hepatic lymphorrhea J Vasc Interv Radiol. 2014 25 1 149 50 10.1016/j.jvir.2013.09.002 24365510
Guez D, Nadolski GJ, Pukenas BA, Itkin M. Transhepatic lymphatic embolization of intractable hepatic lymphorrhea. J Vasc Interv Radiol. 2014;25(1):149–50.24365510
39. Gilliland JD Spies JB Brown SB Yrizarry JM Greenwood LH Lymphoceles: percutaneous treatment with povidone-iodine sclerosis Radiology. 1989 171 1 227 9 10.1148/radiology.171.1.2648473 2648473
Gilliland JD, Spies JB, Brown SB, Yrizarry JM, Greenwood LH. Lymphoceles: percutaneous treatment with povidone-iodine sclerosis. Radiology. 1989;171(1):227–9.2648473
40. Karcaaltincaba M Akhan O Radiologic imaging and percutaneous treatment of pelvic lymphocele Eur J Radiol. 2005 55 3 340 54 10.1016/j.ejrad.2005.03.007 15885959
Karcaaltincaba M, Akhan O. Radiologic imaging and percutaneous treatment of pelvic lymphocele. Eur J Radiol. 2005;55(3):340–54.15885959
41. Chaudry G Burrows PE Padua HM Dillon BJ Fishman SJ Alomari AI Sclerotherapy of abdominal lymphatic malformations with doxycycline J Vasc Interv Radiol. 2011 22 10 1431 5 10.1016/j.jvir.2011.06.021 21821431
Chaudry G, Burrows PE, Padua HM, Dillon BJ, Fishman SJ, Alomari AI. Sclerotherapy of abdominal lymphatic malformations with doxycycline. J Vasc Interv Radiol. 2011;22(10):1431–5.21821431
42. Hamza A Fischer K Koch E Wicht A Zacharias M Loertzer H Fornara P Diagnostics and therapy of lymphoceles after kidney transplantation Transplant Proc. 2006 38 3 701 6 10.1016/j.transproceed.2006.01.065 16647449
Hamza A, Fischer K, Koch E, Wicht A, Zacharias M, Loertzer H, Fornara P. Diagnostics and therapy of lymphoceles after kidney transplantation. Transplant Proc. 2006;38(3):701–6.16647449
43. Moussa AM Aly AK Maybody M Camacho JC Ridouani F Gonzalez-Aguirre AJ Santos E A comparison of lymphatic embolization and sclerotherapy in the management of iatrogenic abdominopelvic lymphoceles following oncological surgery Diagn Interv Radiol. 2023 29 3 542 547 10.4274/dir.2023.232135 37171042
Moussa AM, Aly AK, Maybody M, Camacho JC, Ridouani F, Gonzalez-Aguirre AJ, Santos E. A comparison of lymphatic embolization and sclerotherapy in the management of iatrogenic abdominopelvic lymphoceles following oncological surgery. Diagn Interv Radiol. 2023;29(3):542–7.37171042
44. Pamarthi V Stecker MS Schenker MP Baum RA Killoran TP Suzuki Han A O'Horo SK Rabkin DJ Fan CM Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients J Vasc Interv Radiol. 2014 25 9 1398 404 10.1016/j.jvir.2014.03.027 24837980
Pamarthi V, Stecker MS, Schenker MP, Baum RA, Killoran TP, Suzuki Han A, O’Horo SK, Rabkin DJ, Fan CM. Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients. J Vasc Interv Radiol. 2014;25(9):1398–404.24837980
